The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...
The Royal Marsden NHS Foundation Trust is a world-leading specialist cancer hospital. The Institute of Cancer Research works in close partnership with The Royal Marsden to take the results of our ...
Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for every person with cancer who wants to ...
We identified the breast cancer gene BRCA2, which enabled families with a history of breast cancer to be assessed for future risk, and laid the groundwork for developing novel forms of therapy for ...
We have made huge strides in research and treatment for children with cancer, improving their chances of survival. With your support today, we can discover kinder treatments and offer more children ...
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK. This course provides the theoretical background and training necessary for the management ...
We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...
The Institute of Cancer Research believes that animal research is essential to understand how cancers develop and behave within a whole organism, and how to treat it effectively. We use animal studies ...
More than 110,000 women were recruited from across the UK from 2004 to 2011. The study collects extensive, high-quality data through participant recruitment and follow up questionnaires; blood samples ...
The Institute of Cancer Research, London, works closely with a number of funding organisations, including Cancer Research UK, Breast Cancer Now and the Wellcome Trust. We also have a close partnership ...
We transformed care for advanced prostate cancer, by validating inhibitors of androgen production as an effective cancer treatment, and discovering and developing abiraterone, a life-extending ...